Stem/progenitor cells in mouse mammary gland development and breast cancer

Journal of Mammary Gland Biology and Neoplasia

Volumn 10, Issue 1, 2005, Pages 17-24

  Li, Yi ^a   Rosen, Jeffrey M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; ErbB2 HER2 Neu; Mammary gland; Stem progenitor cells; Wnt

Indexed keywords

CELL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; WNT PROTEIN;

ARTICLE; BREAST CANCER; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; GENETIC ENGINEERING; MAMMARY GLAND; MOUSE; MYOEPITHELIUM; NONHUMAN; ONCOGENE; STEM CELL; TARGET CELL; TRANSGENE;

ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, ANIMAL; MICE; STEM CELLS;

EID: 19444385094     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10911-005-2537-2     Document Type: Article

References (54)

1. DeOme K.B. Faulkin L.J. Jr, Bern H.A. Blair P.B. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 1959;19:515-520.
2. Smith G.H. Medina D. A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland. J Cell Sci 90 (Pt 1) 1988;173-183. 3198708
3. Kordon E.C. Smith G.H. An entire functional mammary gland may comprise the progeny from a single cell. Development 1998;125:1921-1930.
4. Smith G.H. Experimental mammary epithelial morphogenesis in an in vivo model: Evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res Treat 1996;39:21-31.
5. Smith G.H., Boulanger C.A. Mammary epithelial stem cells: Transplantation and self-renewal analysis. Cell Prolif 36 (Suppl) 2003;1:3-15.
6. Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol 2004;51:1-28.
7. Land C.E., McGregor D.H. Breast cancer incidence among atomic bomb survivors: Implications for radiobiologic risk at low doses. J. Natl. Cancer Inst. 1979;62:17-21.
8. Rosen P.R., Groshen S., Saigo P.E., Kinne D.W., Hellman S. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J. Clin. Oncol. 1989;7:355-366.
9. Behbod F., Rosen J.M. Will cancer stem cells provide new therapeutic targets? Carcinogenesis. 2005;26:708-711. doi:10.1093/carcin/bgh293
10. Singh S.K. Hawkins C. Clarke I.D. Squire J.A. Bayani J. Hide T. Henkelman R.M. Cusimano M.D. Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004;432:396-401.
11. Al-Hajj M. Wicha M.S. Benito-Hernandez A. Morrison S.J. Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003;100:3983-3988.
12. Jamieson C.H. Ailles L.E. Dylla S.J. Muijtjens M. Jones C. Zehnder J.L. Gotlib J. Li K. Manz M.G. Keating A. Sawyers C.L. Weissman I.L. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 2004;351:657-667.
13. Welm B.E., Tepera S.B., Venezia T., Graubert T.A., Rosen J.M., Goodell M.A. Sca-1(pos) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev Biol 2002;245:42-56. 10.1006/ dbio.2002.0625
14. Goodell M.A., Brose K., Paradis G., Conner A.S., Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 1996;183:1797-1806. 10.1084/ jem.183.4.1797
15. Alvi A.J., Clayton H., Joshi C., Enver T., Ashworth A., Vivanco M.M., Dale T.C., Smalley M.J. Functional and molecular characterisation of mammary side population cells. Breast Cancer Res. 2003;5:R1-R8. 10.1186/ bcr563
16. Clayton H., Titley I., Vivanco M. Growth and differentiation of progenitor/stem cells derived from the human mammary gland. Exp. Cell Res. 2004;297:444-4460. 10.1016/j.yexcr.2004.03.029
17. Clarke R.B., Spence K., Anderson E., Howell A., Okano H., Potten C.S. A putative human breast population is enriched for steroid-receptor-positive cells Dev. Biol. 2005;277:443-456. 10.1016/ j.ydbio.2004.07.044
18. Clarke R.B. Anderson E. Howell A. Potten C.S. Regulation of human breast epithelial stem cells. Cell Prolif 36 (Suppl 1) 2003;45-58. 10.1046/ j.1365-2184.36.s.1.5.x
19. Gottesman M.M. Fojo T. Bates S.E. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat. Rev. Cancer 2002;2:48-58. 1:CAS:528:DC%2BD38XhvF2jtL8%3D
20. Hirschmann-Jax C. Foster A.E. Wulf G.G. Nuchtern J.G. Jax T.W. Gobel U. Goodell M.A. Brenner M.K. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. USA 2004;101:14228-14233. 10.1073/pnas.0400067101
21. Krishnamurthy P. Ross D.D. Nakanishi T. Bailey-Dell K. Zhou S. Mercer K.E. Sarkadi B. Sorrentino B.P. Schuetz J.D. The stem cell marker Bcrp/ ABCG2 enhances hypoxic cell survival through interactions with heme. J. Biol. Chem. 2004;279:24218-24225. 10.1074/jbc.M313599200
22. Triel C. Vestergaard M.E. Bolund L. Jensen T.G. Jensen U.B. Side population cells in human and mouse epidermis lack stem cell characteristics. Exp. Cell Res. 2004;295:79-90. 10.1016/ j.yexcr.2003.11.032
23. Terunuma A. Jackson K.L. Kapoor V. Telford W.G. Vogel J.C. Side population keratinocytes resembling bone marrow side population stem cells are distinct from label-retaining keratinocyte stem cells. J. Invest. Dermatol. 2003;121:1095-1003. 10.1046/j.1523-1747.2003.12531.x
24. Rock K.L. Reiser H. Bamezai A. McGrew J. Benacerraf B. The LY-6 locus: A multigene family encoding phosphatidylinositol-anchored membrane proteins concerned with T-cell activation. Immunol. Rev. 1989;111:195-224. 1:CAS:528:DyaK3cXlslak
25. Danielson K.G., Oborn C.J., Durban E.M., Butel J.S., Medina D. Epithelial mouse mammary cell line exhibiting normal morphogenesis in vivo and functional differentiation in vitro. Proc. Natl. Acad. Sci. USA 1984;81:3756-3760. 1:CAS:528:DyaL2cXks12qu7g%3D
26. Smith G.H. Mehrel T. Roop D.R. Differential keratin gene expression in developing, differentiating, preneoplastic, and neoplastic mouse mammary epithelium. Cell Growth Differ. 1990;1:161-170. 1:CAS:528:DyaK38XitFajsr8%3D
27. Li Y. Welm B. Podsypanina K. Huang S. Chamorro M. Zhang X. Rowlands T. Egeblad M. Cowin P. Werb Z. Tan L.K. Rosen J.M. Varmus H.E. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 2003;100:15853-15858. 10.1073/pnas.2136825100
28. Paladini R.D. Takahashi K. Bravo N.S. Coulombe P.A. Onset of re-epithelialization after skin injury correlates with a reorganization of keratin filaments in wound edge keratinocytes: Defining a potential role for keratin 16. J Cell Biol. 1996;132:381-397. 10.1083/jcb.132.3.381
29. Sell S. Pierce G.B. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab. Invest. 1994;70:6-22. 1:STN:280:ByuC3szmtlU%3D
30. Reya T. Morrison S.J. Clarke M.F. Weissman I.L. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111. 10.1038/35102167
31. Dai C. Holland E.C. Astrocyte differentiation states and glioma formation. Cancer J. 2003;9:72-81. 1:CAS:528:DC%2BD3sXlsVelsbo%3D
32. Hatsell S. Rowlands T. Hiremath M. Cowin P. Beta-catenin and Tcfs in mammary development and cancer. J. Mammary Gland Biol. Neoplasia 2003;8:145-158. 10.1023/A:1025944723047
33. Brennan K.R. Brown A.M. Wnt proteins in mammary development and cancer. J. Mammary Gland Biol. Neoplasia 2004;9:119-131. 10.1023/ B:JOMG.0000037157.94207.33
34. Sato N. Meijer L. Skaltsounis L. Greengard P. Brivanlou A.H. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 2004;10:55-63. 10.1038/nm979
35. Alonso L. Fuchs E. Stem cells in the skin: Waste not, Wnt not. Genes Dev. 2003;17:1189-1200. 10.1101/gad.1086903
36. Rattis F.M. Voermans C. Reya T. Wnt signaling in the stem cell niche. Curr. Opin. Hematol. 2004;11:88-94. 10.1097/01.moh.0000133649.61121.ec
37. Sancho E. Batlle E. Clevers H. Signaling pathways in intestinal development and cancer. Annu. Rev. Cell Dev. Biol. 2004;20:695-723. 1:CAS:528:DC%2BD2cXhtVejsr7N
38. Liu B.Y. McDermott S.P. Khwaja S.S. Alexander C.M. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc. Natl. Acad. Sci. USA 2004;101:4158-4163. 10.1073/pnas.0400699101
39. Cui X.S. Donehower L.A. Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53. Oncogene 2000;19:5988-5996. 1:CAS:528:DC%2BD3MXhsFCktw%3D%3D
40. Abd El-Rehim D.M. Pinder S.E. Paish C.E. Bell J. Blamey R.W. Robertson J.F. Nicholson R.I. Ellis I.O. Expression of luminal and basal cytokeratins in human breast carcinoma. J. Pathol. 2004;203:661-671. 15141381
41. Perou C.M. Sorlie T. Eisen M.B. van de Rijn M. Jeffrey S.S. Rees C.A. Pollack J.R. Ross D.T. Johnsen H. Akslen L.A. Fluge O. Pergamenschikov A. Williams C. Zhu S.X. Lonning P.E. Borresen-Dale A.L. Brown P.O. Botstein D. Molecular portraits of human breast tumours. Nature 2000;406:747-752. 1:CAS:528:DC%2BD3cXmt1CnsLw%3D
42. Sorlie T. Tibshirani R. Parker J. Hastie T. Marron J.S. Nobel A. Deng S. Johnsen H. Pesich R. Geisler S. Demeter J. Perou C.M. Lonning P.E. Brown P.O. Borresen-Dale A.L. Botstein D. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA 2003;100:8418-8423. 1:CAS:528:DC%2BD3sXlsFGntLk%3D
43. Sorlie T. Perou C.M. Tibshirani R. Aas T. Geisler S. Johnsen H. Hastie T. Eisen M.B. van de Rijn M. Jeffrey S.S. Thorsen T. Quist H. Matese J.C. Brown P.O. Botstein D. Eystein Lonning P. Borresen-Dale A.L. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 2001;98:10869-10874. 1:CAS:528:DC%2BD3MXntVGmsbo%3D
44. Turner N. Tutt A. Ashworth A. Hallmarks of "BRCAness" in sporadic cancers. Nat. Rev. Cancer 2004;4:814-819. 1:CAS:528:DC%2BD2cXos1ymu7g%3D
45. Andrechek E.R. Hardy W.R. Laing M.A. Muller W.J. Germ-line expression of an oncogenic erbB2 allele confers resistance to erbB2-induced mammary tumorigenesis. Proc. Natl. Acad. Sci. USA 2004;101:4984-4989. 1:CAS:528:DC%2BD2cXjsFCis7g%3D
46. Yu Q. Geng Y. Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature 2001;411:1017-1021. 10.1038/35082500
47. Henry M.D. Triplett A.A. Oh K.B. Smith G.H. Wagner K.U. Parity-induced mammary epithelial cells facilitate tumorigenesis in MMTV-Neu transgenic mice. Oncogene 2004;23:6980-6985. 1:CAS:528:DC%2BD2cXnsFaitrg%3D
48. Boulanger C.A. Wagner K.U. Smith G.H. Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to TGF-beta1 expression. Oncogene 2004.
49. Morrison B.W. Leder P. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene 1994;9:3417-3426. 1:CAS:528:DyaK2MXisFWrsL8%3D
50. Dontu G. Abdallah W.M. Foley J.M. Jackson K.W. Clarke M.F. Kawamura M.J. Wicha M.S. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003;17:1253-1270. 10.1101/ gad.1061803
51. D'Cruz C.M. Gunther E.J. Boxer R.B. Hartman J.L. Sintasath L. Moody S.E. Cox J.D. Ha S.I. Belka G.K. Golant A. Cardiff R.D. Chodosh L.A. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat. Med. 2001;7:235-239. 1:CAS:528:DC%2BD3MXhtVyksbk%3D
52. Fisher G.H. Orsulic S. Holland E. Hively W.P. Li Y. Lewis B.C. Williams B.O. Varmus H.E. Development of a flexible and specific gene delivery system for production of murine tumor models. Oncogene 1999;18:5253-5260. 1:CAS:528:DyaK1MXms1Onsb8%3D
53. Lewis B.C. Chinnasamy N. Morgan R.A. Varmus H.E. Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vector. J Virol 2001;75:9339-9344. 1:CAS:528:DC%2BD3MXntVGqs7w%3D
54. Smith G.H. Label-retaining epithelial cells in mouse mammary gland divide asymmetrically and retain their template DNA strands. Development 2005;132:681-687. 681-687. 10.1242/dev.01609